ARDSLEY ADVISORY PARTNERS LP Q2 2020 Filing

Filed August 14, 2020

Portfolio Value

$470.1M

Holdings

125

Report Date

Q2 2020

Filing Type

13F-HR

All Holdings (125 positions)

#StockSharesValue% PortfolioType
101
8INSYNEOS HEALTH INC
5,000$291K0.06%
102
ADMAADMA BIOLOGICS INC
97,100$285K0.06%
103
QRVOQORVO INC
2,500$276K0.06%
104
2L9BLUEPRINT MEDICINES CORP
3,500$273K0.06%
105
ALDXALDEYRA THERAPEUTICS INC
62,100$259K0.06%
106
FATEFATE THERAPEUTICS INC
7,500$257K0.05%
107
GMABGENMAB A/S
7,500$254K0.05%
108
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
27,091$251K0.05%
109
GTMZOOMINFO TECHNOLOGIES INC
4,000$204K0.04%Put
110
VSTVISTRA ENERGY CORP
10,000$186K0.04%
111
FLBFLUIDIGM CORP DEL
40,000$160K0.03%
112
HROWHARROW HEALTH INC
30,000$156K0.03%
113
GENMARK DIAGNOSTICS INC
10,000$147K0.03%
114
ABEONA THERAPEUTICS INC
50,000$146K0.03%
115
APTOSE BIOSCIENCES INC
19,750$125K0.03%
116
ERICERICSSON
11,000$102K0.02%
117
SEELOS THERAPEUTICS INC
80,000$81K0.02%
118
CSTMCONSTELLIUM SE
10,000$77K0.02%
119
APOLLO ENDOSURGERY INC
45,188$74K0.02%
120
ACTINIUM PHARMACEUTICALS INC
130,000$46K0.01%
121
AZURRX BIOPHARMA INC
30,000$27K0.01%
122
WAITR HLDGS INC
10,000$26K0.01%
123
T-MOBILE US INC
151,810$26K0.01%
124
VTNRUSDVERTEX ENERGY INC
17,893$10K0.00%
125
GSMFERROGLOBE PLC
10,000$5K0.00%
PreviousPage 2 of 2